Kali-Extracts Inc. Cannabis Pharmaceutical Value Highlighted In Goldman Small Cap Research Report

Kali Extracts

DALLAS, Jan. 09, 2019 (GLOBE NEWSWIRE) — via OTC PR WIRE — Kali, Inc. (dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today featured segments of the Goldman Small Cap Research Report published yesterday that highlight KALY’s cannabis pharmaceutical value: “Prior to the acquisition by Kali-Extracts, NCM Biotech was engaged with a number of different universities on a number of separate research initiatives. …

Read More